There are no conversations in this channel.
Please log in to your account to view your subscribed posts.
| Topics | Statistics | Last Post | ||
|---|---|---|---|---|
|
4 responses
2,433 views
0 reactions
|
by Lindeboom
07-25-2016, 12:45 AM
|
|||
|
0 responses
1,603 views
0 reactions
|
by Lindeboom
07-25-2016, 12:38 AM
|
|||
|
4 responses
2,104 views
0 reactions
|
by kgoglin
07-22-2016, 10:38 AM
|
|||
|
1 response
1,629 views
0 reactions
|
by dpryan
07-22-2016, 12:32 AM
|
|||
|
14 responses
16,905 views
0 reactions
|
by cerbatana
07-21-2016, 07:18 AM
|
|||
|
9 responses
3,044 views
0 reactions
|
by Genohub
07-19-2016, 05:31 PM
|
|||
|
9 responses
6,241 views
0 reactions
|
07-19-2016, 11:36 AM
|
|||
|
4 responses
2,147 views
0 reactions
|
07-19-2016, 12:07 AM
|
|||
|
1 response
1,630 views
0 reactions
|
by FWOS
07-18-2016, 10:41 AM
|
|||
|
10 responses
3,891 views
0 reactions
|
07-13-2016, 11:41 PM
|
No topics found.
-
Next-generation sequencing (NGS) is now central to outbreak investigations and antimicrobial resistance tracking. Through sophisticated...07-31-2026, 07:00 AM
-
The immune system’s power comes from its genetic diversity, allowing myriad threats to be neutralized through first recognizing foreign antigens. That diversity is also what makes the immune system so difficult to study. Recent advances in sequencing technology and computational biology, however, are giving researchers new tools to understand immune responses and immune-related diseases in greater detail.
This convergence of genetics, immunology, and computation...09-01-2026, 05:41 AM -
CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).
Despite this, “CRISPR helped turn genome editing from a specialized technique into...07-31-2026, 11:01 AM
